Cadila Healthcare gets USFDA approval for Metoprolol Succinate tablets
Cadila Healthcare has received final approval to market Metoprolol Succinate extended-release tablets, from USFDA in the strengths of 25mg, 50mg, 100mg and 200mg. The tablet will be manufactured...